Transcatheter Embolization and Occlusion Devices Market Size, Share, Analysis Report

TOLL FREE NUMBER +1-855-984-1862

FOR QUICK HELP +91-860-565-7204

Transcatheter Embolization and Occlusion Devices Market By Product Type (Embolizataion Coils, Embolization Particles, Coiling Assist Devices, Flow Diverter Devices, Liquid Embolics, and Accessories); By Application (Peripheral Vascular Disease, Neurology, Oncology, Urology); By End-users - Global Industry Analysis and Forecast 2023 - 2028

The Transcatheter Embolization and Occlusion Devices market is expected to be around US$ 5.60 Billion by 2028; Growing at a CAGR of more than 7.5% in the given forecast period.

COVID-19 Impact Analysis Report

"Get Latest Updated Reports as per the COVID-19 Impact"

Infopedia: Access Our All Reports Online at Affordable Price

CLICK HERE

MARKET SNAPSHOT

Major Players

St. Jude Medical Inc
Abbott Laboratories
Medtronic plc
BTG plc
Boston Scientific Corporation

Study period:

Fastest Growing Market:

2023-2028

APAC

Base Year:

Largest Market:

2022

North America

CAGR:

REPORT DESCRIPTION

Transcatheter embolization is a method of insertion synthetic material or medication called embolic agent into blood vessel during catheter to block the blood flow in the direction of a specific area of the body. Embolization is a very efficient method to prevent anomalous bleeding and is simply enveloping as compared to open surgery. The transcatheter embolization and occlusion devices market have observed physically powerful development in the past few years because of the increasing focus on improvement, resulting in superior product approvals and product launches around the word. The market is also differentiating by considerable research and progress leading to numerous technological innovations.
How Big is the Transcatheter Embolization and Occlusion Devices Market?

The Transcatheter Embolization and Occlusion Devices market is expected to be around US$ 5.60 Billion by 2028; Growing at a CAGR of more than 7.5% in the given forecast period.

The major driving factors of Transcatheter Embolization & Occlusion devices market are as follows:

•   Increasing prevalence of cancer
•   Rising approval of minimally invasive surgeries

The restraining factors of Transcatheter Embolization and Occlusion devices market are as follows:

•   High rate of the products.
•   Need of skilled professionals

The transcatheter embolization and occlusion devices market is segmented on the lines of its product, end user, application and regional. Product is further segmented into accessories, embolization particles, embolization coils, liquid embolics and flow diverter devices. Accessories consist of catheters, guidewires and others. Under embolization particles segmentation it covers drug eluting beads, microspheres, radio embolization particles and others. Under embolization coils segmentation it covers balloon assisted coiling, stent assisted coiling, coiling assist devices, detachable and pushable. Based on end user segmentation it covers hospitals, ambulatory surgical centers and clinics. Based on application segmentation it covers peripheral vascular disease, neurology, oncology, urology and others. The transcatheter embolization and occlusion devices market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for transcatheter embolization and occlusion devices and related technologies.

2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.

3) Identifications of new market opportunities and targeted promotional plans for transcatheter embolization and occlusion devices.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Transcatheter Embolization and Occlusion Devices Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include St. Jude Medical, Inc., Abbott Laboratories,Medtronic plc, BTG plc, Boston Scientific Corporation, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Transcatheter Embolization & Occlusion Devices Market has been segmented as below:

By Product Segment Analysis

•   Accessories
o   Catheters
o   Guidewires
o   Others

•   Embolization particles
o   Drug eluting beads
o   Microspheres
o   Radioembolization particles
o   Others

•   Embolization coils
o   Balloon assisted coiling
o   Stent assisted coiling
o   Coiling assist devices
o   Detachable
o   Pushable

•   Liquid embolics

•   Flow diverter devices

By End-user Analysis

•   Hospitals
•   Ambulatory Surgical Centers
•   Clinics

By Application Analysis

•   Peripheral Vascular Disease
•   Neurology
•   Oncology
•   Urology
•   Others

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:

1) Obtain the most up to date information available on all transcatheter embolization and occlusion devices.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of transcatheter embolization and occlusion devices data.
4) Assess your competitor’s refining portfolio and its evolution.

Customization:
We can offer you custom research reports as per client’s special requirements.

Below are our new reports:

Dental Consumables Market

Dental Diagnostic & Surgical Equipment Market

Dental Equipment Manufacturing Market

Dental Equipment Market

Dental Hygiene Devices market

1 INTRODUCTION
    1.1    Key Take Aways
   1.2    Report Description
   1.3    Markets Covered
   1.4    Stakeholders
   1.5    Research Methodology
       1.5.1    Market Size
       1.5.2    Market Share
       1.5.3    Key Data Points From Secondary Sources
       1.5.4    Key Data Points From Primary Sources

2. Assumptions and Research Methodology

3. Executive Summary: Transcatheter Embolization and Occlusion Devices Market

4. Market Overview
    4.1. Introduction
           4.1.1. Product Definition
           4.1.2. Industry Evolution / Developments
    4.2. Market Overview
    4.3. Market Dynamics
           4.3.1. Drivers
           4.3.2. Restraints
           4.3.3. Opportunity
    4.4. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, 2022–2027
           4.4.1. Market Volume Projections, 2022–2027 (Units)
           4.4.2. Market Revenue Projections (US$ Mn)
    4.5. Porter’s Five Force Analysis
    4.6. Value Chain Analysis
    4.7. Market Outlook

5. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by Product
    5.1. Introduction & Definition
    5.2. Key Findings / Developments
    5.3. Key Trends
    5.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product Type, 2022–2027
           5.2.1. Embolization Coils
                   5.2.1.1. Pushable
                   5.2.1.2. Detachable
           5.2.2. Coiling Assist Devices
                   5.2.2.1. Stent Assist
                   5.2.2.2. Balloon Assist
           5.2.3. Embolization Particles
                   5.2.3.1. Radioembolization Spheres
                   5.2.3.2. Microspheres
                   5.2.3.3. Drug eluting Beads
                   5.2.3.4. Others
           5.2.4. Flow Diverting Devices
           5.2.5. Liquid Embolics Accessories
                   5.2.5.1. Catheters
                   5.2.5.2. Guidewires
                   5.2.5.3. Others
    5.3. Market Attractiveness, by Product Type, 2015

6. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by Application, 2016–2024
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Key Trends
    6.4. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application, 2022–2027
           6.4.1. Peripheral Vascular Disease
           6.4.2. Neurology
           6.4.3. Oncology
           6.4.4. Urology
           6.4.5. Others
    6.5. Market Attractiveness, by Application, 2015

7. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by End-user, 2016–2024
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Key Trends
    7.4. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user, 2022–2027
           7.4.1. Hospitals
           7.4.2. Ambulatory Centers
           7.4.3. Clinics
    7.5. Market Attractiveness, by End-user, 2015

8. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by Region, 2016–2024
    8.1. Key Findings
    8.2. Policies and Regulations
    8.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Region, 2022–2027
           8.3.1. North America
           8.3.2. Latin America
           8.3.3. Europe
           8.3.4. Asia Pacific
           8.3.5. Middle East and Africa
    8.4. Market Attractiveness, by Country/Region, 2022

9. North America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2015–2025
    9.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product
           9.1.1. Embolization Coils
                   9.1.1.1. Pushable
                   9.1.1.2. Detachable
           9.1.2. Coiling Assist Devices
                   9.1.2.1. Stent Assist
                   9.1.2.2. Balloon Assist
           9.1.3. Embolization Particles
                   9.1.3.1. Radioembolization Spheres
                   9.1.3.2. Microspheres
                   9.1.3.3. Drug eluting Beads
                   9.1.3.4. Others
           9.1.4. Flow Diverting Devices
           9.1.5. Liquid Embolics Accessories
                   9.1.5.1. Catheters
                   9.1.5.2. Guidewires
                   9.1.5.3. Others
    9.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
           9.2.1. Peripheral Vascular Disease
           9.2.2. Neurology
           9.2.3. Oncology
           9.2.4. Urology
           9.2.5. Others
    9.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
           9.3.1. Hospitals
           9.3.2. Ambulatory Centers
           9.3.3. Clinics
    9.4. North America Market, by Country, (US$), 2022–2027
           9.4.1. U.S.
           9.4.2. Canada
    9.5. Market Attractiveness, by Country, 2022
    9.6. Market Attractiveness, by Product type, 2022
    9.7. Market Attractiveness, by Application, 2022
    9.8. Market Attractiveness, by End-user, 2022

10. Europe Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast
    10.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product
           10.1.1. Embolization Coils
                   10.1.1.1. Pushable
                   10.1.1.2. Detachable
           10.1.2. Coiling Assist Devices
                   10.1.2.1. Stent Assist
                   10.1.2.2. Balloon Assist
           10.1.3. Embolization Particles
                   10.1.3.1. Radioembolization Spheres
                   10.1.3.2. Microspheres
                   10.1.3.3. Drug eluting Beads
                   10.1.3.4. Others
           10.1.4. Flow Diverting Devices
           10.1.5. Liquid Embolics Accessories
                   10.1.5.1. Catheters
                   10.1.5.2. Guidewires
                   10.1.5.3. Others
    10.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
           10.2.1. Peripheral Vascular Disease
           10.2.2. Neurology
           10.2.3. Oncology
           10.2.4. Urology
           10.2.5. Others
    10.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
           10.3.1. Hospitals
           10.3.2. Ambulatory Centers
           10.3.3. Clinics
    10.4. Europe Market, by Country, (US$), 2022–2027
           10.4.1. U.K.
           10.4.2. Germany
           10.4.3. Rest of Europe
    10.5. Market Attractiveness, by Country, 2022
    10.6. Market Attractiveness, by Product type, 2022
    10.7. Market Attractiveness, by Application, 2022
    10.8. Market Attractiveness, by End-user, 2022

11. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2022–20227
    11.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product
           11.1.1. Embolization Coils
                   11.1.1.1. Pushable
                   11.1.1.2. Detachable
           11.1.2. Coiling Assist Devices
                   11.1.2.1. Stent Assist
                   11.1.2.2. Balloon Assist
           11.1.3. Embolization Particles
                   11.1.3.1. Radioembolization Spheres
                   11.1.3.2. Microspheres
                   11.1.3.3. Drug eluting Beads
                   11.1.3.4. Others
           11.1.4. Flow Diverting Devices
           11.1.5. Liquid Embolics Accessories
                   11.1.5.1. Catheters
                   11.1.5.2. Guidewires
                   11.1.5.3. Others
    11.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
           11.2.1. Peripheral Vascular Disease
           11.2.2. Neurology
           11.2.3. Oncology
           11.2.4. Urology
           11.2.5. Others
    11.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
           11.3.1. Hospitals
           11.3.2. Ambulatory Centers
           11.3.3. Clinics
    11.4. Asia Pacific Market, by Country, (US$), 2015–2025
           11.4.1. China
           11.4.2. Japan
           11.4.3. India
           11.4.4. Australia
           11.4.5. Rest of APAC
    11.5. Market Attractiveness, by Country, 2022
    11.6. Market Attractiveness, by Product type, 2022
    11.7. Market Attractiveness, by Application, 2022
    11.8. Market Attractiveness, by End-user, 2022

12. Latin America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2022–2027
    12.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast by Product
           12.1.1. Embolization Coils
                   12.1.1.1. Pushable
                   12.1.1.2. Detachable
           12.1.2. Coiling Assist Devices
                   12.1.2.1. Stent Assist
                   12.1.2.2. Balloon Assist
           12.1.3. Embolization Particles
                   12.1.3.1. Radioembolization Spheres
                   12.1.3.2. Microspheres
                   12.1.3.3. Drug eluting Beads
                   12.1.3.4. Others
           12.1.4. Flow Diverting Devices
           12.1.5. Liquid Embolics Accessories
                   12.1.5.1. Catheters
                   12.1.5.2. Guidewires
                   12.1.5.3. Others
    12.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
           12.2.1. Peripheral Vascular Disease
           12.2.2. Neurology
           12.2.3. Oncology
           12.2.4. Urology
           12.2.5. Others
    12.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
           12.3.1. Hospitals
           12.3.2. Ambulatory Centers
           12.3.3. Clinics
    12.4. Latin America Market, by Country, (US$), 2015–2025
           12.4.1. Brazil
           12.4.2. Mexico
           12.4.3. Rest of LATAM
    12.5. Market Attractiveness, by Country, 2015
    12.6. Market Attractiveness, by Product type, 2015
    12.7. Market Attractiveness, by Application, 2015
    12.8. Market Attractiveness, by End-user, 2015

13. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2022–2027
    13.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast by Product
           13.1.1. Embolization Coils
                   13.1.1.1. Pushable
                   13.1.1.2. Detachable
           13.1.2. Coiling Assist Devices
                   13.1.2.1. Stent Assist
                   13.1.2.2. Balloon Assist
           13.1.3. Embolization Particles
                   13.1.3.1. Radioembolization Spheres
                   13.1.3.2. Microspheres
                   13.1.3.3. Drug eluting Beads
                   13.1.3.4. Others
           13.1.4. Flow Diverting Devices
           13.1.5. Liquid Embolics Accessories
                   13.1.5.1. Catheters
                   13.1.5.2. Guidewires
                   13.1.5.3. Others
    13.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
           13.2.1. Peripheral Vascular Disease
           13.2.2. Neurology
           13.2.3. Oncology
           13.2.4. Urology
           13.2.5. Others
    13.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
           13.3.1. Hospitals
           13.3.2. Ambulatory Centers
           13.3.3. Clinics
    13.4. Middle East & Africa Market, by Country, (US$), 2015–2025
           13.4.1. UAE
           13.4.2. South Africa
           13.4.3. Rest of Middle East & Africa

14. Competition Landscape
    14.1. Market Player - Competition Matrix (by Tier and Size of companies)
    14.2. Market Share Analysis, by Company (2015)
    14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
           14.3.1. Abbott Laboratories
                   14.3.1.1. Company Details
                   14.3.1.2. Company Description
                   14.3.1.3. Business Overview
                   14.3.1.4. SWOT Analysis
                   14.3.1.5. Financials
                   14.3.1.6. Strategic Overview
                   14.3.1.7. Product Portfolio
                   14.3.1.8. Recent Developments
           14.3.2. Boston Scientific Corporation
                   14.3.2.1. Company Details
                   14.3.2.2. Company Description
                   14.3.2.3. Business Overview
                   14.3.2.4. SWOT Analysis
                   14.3.2.5. Financials
                   14.3.2.6. Strategic Overview
                   14.3.2.7. Product Portfolio
                   14.3.2.8. Recent Developments
           14.3.3. BTG International Ltd
                   14.3.3.1. Company Details
                   14.3.3.2. Company Description
                   14.3.3.3. Business Overview
                   14.3.3.4. SWOT Analysis
                   14.3.3.5. Financials
                   14.3.3.6. Strategic Overview
                   14.3.3.7. Product Portfolio
                   14.3.3.8. Recent Developments
           14.3.4. Cook Medical
                   14.3.4.1. Company Details
                   14.3.4.2. Company Description
                   14.3.4.3. Business Overview
                   14.3.4.4. SWOT Analysis
                   14.3.4.5. Financials
                   14.3.4.6. Strategic Overview
                   14.3.4.7. Product Portfolio
                   14.3.4.8. Recent Developments
           14.3.5. Edward Lifesciences
                   14.3.5.1. Company Details
                   14.3.5.2. Company Description
                   14.3.5.3. Business Overview
                   14.3.5.4. SWOT Analysis
                   14.3.5.5. Financials
                   14.3.5.6. Strategic Overview
                   14.3.5.7. Product Portfolio
                   14.3.5.8. Recent Developments
           14.3.6. Johnson & Johnson
                   14.3.6.1. Company Details
                   14.3.6.2. Company Description
                   14.3.6.3. Business Overview
                   14.3.6.4. SWOT Analysis
                   14.3.6.5. Financials
                   14.3.6.6. Strategic Overview
                   14.3.6.7. Product Portfolio
                   14.3.6.8. Recent Developments
           14.3.7. Medtronic, plc
                   14.3.7.1. Company Details
                   14.3.7.2. Company Description
                   14.3.7.3. Business Overview
                   14.3.7.4. SWOT Analysis
                   14.3.7.5. Financials
                   14.3.7.6. Strategic Overview
                   14.3.7.7. Product Portfolio
                   14.3.7.8. Recent Developments
           14.3.8. Merit Medical Systems, Inc.
                   14.3.8.1. Company Details
                   14.3.8.2. Company Description
                   14.3.8.3. Business Overview
                   14.3.8.4. SWOT Analysis
                   14.3.8.5. Financials
                   14.3.8.6. Strategic Overview
                   14.3.8.7. Product Portfolio
                   14.3.8.8. Recent Developments
           14.3.9. Penumbra, Inc.
                   14.3.9.1. Company Details
                   14.3.9.2. Company Description
                   14.3.9.3. Business Overview
                   14.3.9.4. SWOT Analysis
                   14.3.9.5. Financials
                   14.3.9.6. Strategic Overview
                   14.3.9.7. Product
                   14.3.9.8. Recent Developments
           14.3.10. Pfizer, Inc.
                   14.3.10.1. Company Details
                   14.3.10.2. Company Description
                   14.3.10.3. Business Overview
                   14.3.10.4. SWOT Analysis
                   14.3.10.5. Financials
                   14.3.10.6. Strategic Overview
                   14.3.10.7. Product Portfolio
                   14.3.10.8. Recent Developments
           14.3.11. Sirtex Medical Limited
                   14.3.11.1. Company Details
                   14.3.11.2. Company Description
                   14.3.11.3. Business Overview
                   14.3.11.4. SWOT Analysis
                   14.3.11.5. Financials
                   14.3.11.6. Strategic Overview
                   14.3.11.7. Product Portfolio
                   14.3.11.8. Recent Developments
           14.3.12. St. Jude Medical, Inc.
                   14.3.12.1. Company Details
                   14.3.12.2. Company Description
                   14.3.12.3. Business Overview
                   14.3.12.4. SWOT Analysis
                   14.3.12.5. Financials
                   14.3.12.6. Strategic Overview
                   14.3.12.7. Product Portfolio
                   14.3.12.8. Recent Developments
           14.3.13. Stryker Corporation
                   14.3.13.1. Company Details
                   14.3.13.2. Company Description
                   14.3.13.3. Business Overview
                   14.3.13.4. SWOT Analysis
                   14.3.13.5. Financials
                   14.3.13.6. Strategic Overview
                   14.3.13.7. Product Portfolio
                   14.3.13.8. Recent Developments
           14.3.14. Terumo Corporation
                   14.3.14.1. Company Details
                   14.3.14.2. Company Description
                   14.3.14.3. Business Overview
                   14.3.14.4. SWOT Analysis
                   14.3.14.5. Financials
                   14.3.14.6. Strategic Overview
                   14.3.14.7. Product Portfolio
                   14.3.14.8. Recent Developments

The Transcatheter Embolization & Occlusion Devices Market has been segmented as below:

By Product Segment Analysis

•   Accessories
o   Catheters
o   Guidewires
o   Others

•   Embolization particles
o   Drug eluting beads
o   Microspheres
o   Radioembolization particles
o   Others

•   Embolization coils
o   Balloon assisted coiling
o   Stent assisted coiling
o   Coiling assist devices
o   Detachable
o   Pushable

•   Liquid embolics

•   Flow diverter devices

By End-user Analysis

•   Hospitals
•   Ambulatory Surgical Centers
•   Clinics

By Application Analysis

•   Peripheral Vascular Disease
•   Neurology
•   Oncology
•   Urology
•   Others

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Report Id: MDTEODM117

Got a question? We've got answers. If you have some other questions, see our support center.

What is the predicted growth rate of Transcatheter Embolization and Occlusion Devices market?

The market is expected to grow at a CAGR of 7.5% during the study period (2023-2028)

How big is the Transcatheter Embolization and Occlusion Devices market value?

The Transcatheter Embolization and Occlusion Devices market is expected to be around US$ 5.60 Billion by 2028.

What is the segment’s covered for the Transcatheter Embolization and Occlusion Devices market?

The segment included in the Transcatheter Embolization and Occlusion Devices market is Product, End-user, Application, and region.

Who are the major key vendors in the Transcatheter Embolization and Occlusion Devices market?

Some key players operating in the Transcatheter Embolization and Occlusion Devices market include St. Jude Medical, Inc., Abbott Laboratories,Medtronic plc, BTG plc, Boston Scientific Corporation, Cook Medical, Inc.

What are the different forms of the report available?

We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

Search form